IEEE

Comparison of ECG-Free Algorithms for Heart Rate Computation From Head-BCG Signals Obtained With Smart Eyewear

Abstract: Ballistocardiography (BCG) is a non-invasive method to assess cardiac activity by detecting body recoil in response to heart contractions and blood flow. Traditionally, BCG technology was ...
Nasdaq

BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System

HeartBeam BEAT recently secured FDA 510(k) clearance for its first-of-its-kind, cable-free synthesized 12-lead ECG technology, marking a major inflection point in the company’s mission to modernize ...
FierceBiotech

HeartBeam swells on turning FDA rejection into ECG clearance

After receiving word late last month that the FDA would not be issuing a 510(k) clearance to its cable-free electrocardiogram, HeartBeam has successfully appealed the decision and now touts a green ...
BioSpace

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

FDA Clearance Granted After Successful Appeal, Overturning Prior Not Substantially Equivalent (NSE) Outcome HeartBeam’s Credit-Card Sized Device Delivers Clinical-Grade Insights Directly to Patients ...
Times Argus

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that the U.S. Food and Drug ...
Yahoo Finance

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

SANTA CLARA, Calif., December 10, 2025--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, ...